Albumin-Induced Neuroprotection in Focal Cerebral Ischemia in the ALIAS Trial: Does Severity, Mechanism, and Time of Infusion Matter?
Crossref DOI link: https://doi.org/10.1007/s12028-017-0400-0
Published Online: 2017-04-24
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khatri, Rakesh
Afzal, Mohammad Rauf
Rodriguez, Gustavo J.
Maud, Alberto
Miran, Muhammad Shah
Qureshi, Mohtashim Arbaab
Cruz-Flores, Salvador
Qureshi, Adnan I.
License valid from 2017-04-24